(CODX) –
-
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
-
Co-Diagnostics (CODX) Announces Management Appointments
-
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
-
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
-
Form 3 Co-Diagnostics, Inc. For: Mar 15 Filed by: Abbott Richard David
-
Co-Diagnostics (CODX) Appoints Richard Abbott as President
-
Form 8-K Co-Diagnostics, Inc. For: Mar 15
-
Co-Diagnostics (CODX) PT Lowered to $2.50 at H.C. Wainwright
-
Co-Diagnostics (CODX) Reports FY Loss of $1.20
-
Form 10-K Co-Diagnostics, Inc. For: Dec 31
-
Form 8-K Co-Diagnostics, Inc. For: Mar 14
-
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
-
Co-Diagnostics (CODX) and JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
-
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
-
Form SC 13G/A Co-Diagnostics, Inc. Filed by: VANGUARD GROUP INC
-
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
-
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
-
Co-Diagnostics (CODX) Completes Submission to FDA for Co-Dx PCR Pro
-
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
-
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: SERBIN RICHARD S
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Durenard Eugene
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: MURPHY TED
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: NELSON JAMES B
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Egan Dwight H
-
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Brown Brian Lee
-
Co-Diagnostics (CODX) PT Raised to $3 at H.C. Wainwright
-
Form 10-Q Co-Diagnostics, Inc. For: Sep 30
-
Co-Diagnostics (CODX) Tops Q3 EPS by 9c
-
Form 8-K Co-Diagnostics, Inc. For: Nov 09
-
Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
-
Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development
-
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023
-
Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast
-
Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25
-
Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa
-
Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28
-
Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece
-
Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
-
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023
-
Form 8-K Co-Diagnostics, Inc. For: Aug 30
-
Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer
-
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.
-
Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand
-
Co-Diagnostics (CODX) PT Lowered to $2 at H.C. Wainwright
-
Form 10-Q Co-Diagnostics, Inc. For: Jun 30
-
Form 8-K Co-Diagnostics, Inc. For: Aug 10
-
Co-Diagnostics (CODX) Misses Q2 EPS by 7c
-
Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results
Back to CODX Stock Lookup
